Monopar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.About MNPR
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages.
MNPR Key Statistics
Stock Snapshot
As of today, Monopar Therapeutics(MNPR) shares are valued at $104.33. The company's market cap stands at 700.28M, with a P/E ratio of -44.63.
On 2026-09-16, Monopar Therapeutics(MNPR) stock moved within a range of $101.89 to $105.71. With shares now at $104.33, the stock is trading +2.4% above its intraday low and -1.3% below the session's peak.
Trading volume for Monopar Therapeutics(MNPR) stock has reached 86.82K, versus its average volume of 119.28K.
The stock's 52-week range extends from a low of $50.07 to a high of $124.82.
The stock's 52-week range extends from a low of $50.07 to a high of $124.82.
Analyst ratings
92%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.